Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.
about
Erythropoietin in ophthalmology: A literature reviewPharmacologic interventions for the prevention and treatment of retinopathy of prematurityRetinopathy of prematurity: current concepts in molecular pathogenesis.The effect of erythropoietin on the severity of retinopathy of prematurityEffects of transfusions in extremely low birth weight infants: a retrospective study.Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic optionsNew-onset maternal gestational hypertension and risk of retinopathy of prematurity.Survey on retinopathy of prematurity (ROP) in Italy.Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration.Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy.Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurityMediators of ocular angiogenesis.Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity.The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment.VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesisUrinary erythropoietin concentrations after early short-term infusion of high-dose recombinant epo for neuroprotection in preterm neonates.VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression.High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats.Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.
P2860
Q26744850-B4746D2E-C69E-4B5B-A07E-B121AD62B318Q26772889-5E07FF11-3486-4CE0-A076-082D624F518DQ33606227-04032A98-81F9-4E98-82B6-F5DE4F790DD8Q33891194-C425DBC3-8CCF-4E00-8489-D8AF9A203344Q34573299-CCA728B0-8DB3-4013-B457-6F063DDCD492Q34704214-D0EB4581-0E9A-46C9-97B4-C8A63577AC0BQ34735110-B0A96586-D005-444C-BEEE-54BCEE040A07Q34803209-BB0294BA-15A5-4614-ABFD-50DE1D5D07D8Q35225120-C34ED5EC-8D66-409D-AD1B-9E611ABCFA42Q36494891-272B3004-8F76-49EF-8B9B-77ECB06FE05FQ36752978-EA8F7C13-F1F6-46A0-9653-195F5D02CF23Q37678807-5AED6D2E-1E43-4377-9999-53E9B0015497Q37828361-63BC8102-2F5F-4A16-BB8B-D25CDED5AABAQ38101684-D559E85A-36D3-4385-AF8B-ECBD58822010Q38110390-E561219C-D004-493B-92D6-DDEBBE770341Q38560836-5D6CB4B5-0DE8-423A-B325-7BAEAEAA8595Q39589208-C3CCECCF-904D-429F-9009-ADB82FA1B84CQ42044757-47A01EFF-DEFD-4B0B-A725-82EC38689AAEQ43289952-F99EEAA9-78B4-44E2-8404-D7B8546EFDADQ43567453-AFE61312-D1CA-43D6-8112-567C90938FCD
P2860
Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Human recombinant erythropoiet ...... : a multiple regression model.
@ast
Human recombinant erythropoiet ...... : a multiple regression model.
@en
type
label
Human recombinant erythropoiet ...... : a multiple regression model.
@ast
Human recombinant erythropoiet ...... : a multiple regression model.
@en
prefLabel
Human recombinant erythropoiet ...... : a multiple regression model.
@ast
Human recombinant erythropoiet ...... : a multiple regression model.
@en
P2093
P1476
Human recombinant erythropoiet ...... : a multiple regression model.
@en
P2093
Anthony Liu
Cheri K Leng
Elba Fayard
Jason K Leng
Jennifer A Dunbar
Kevin K Suk
Noha S Daher
Pauline Lim
Samantha Weller
P304
P356
10.1016/J.JAAPOS.2007.08.009
P577
2008-06-01T00:00:00Z